Showing results (71-80 of 141) with videos related to
Sort By:
Pageof 15
Journal for Immunotherapy of Cancer|January 7, 2021
Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitorsXingxing Hao, Louis D Falo Iii, Guo Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Interferon-alpha (IFN-alpha)-conditioned DC preferentially stimulate type-1 and limit Treg-type in vitro T-cell responses from RCC patientsMargherita Gigante, Maja Mandic, Amy K Wesa, et al.Carcinogenesis|June 28, 2019
Tumor-derived exosomes promote carcinogenesis of murine oral squamous cell carcinomaBeatrice M Razzo, Nils Ludwig, Chang-Sook Hong, et al.Cancer Immunology Research|October 14, 2020
Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with MelanomaDeena M Maurer, Juraj Adamik, Patricia M Santos, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2013
DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculatureNina Chi Sabins, Jennifer L Taylor, Kellsye P L Fabian, et al.Cancer Immunology, Immunotherapy : CII|May 30, 2019
Impact of combination immunochemotherapies on progression of 4NQO-induced murine oral squamous cell carcinomaSonja Ludwig, Chang-Sook Hong, Beatrice M Razzo, et al.Frontiers in Oncology|October 18, 2014
Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer PatientsAmy K Wesa, Maja Mandic, Jennifer L Taylor, et al.Cancer Research|August 9, 2003
Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinomaTomohide Tatsumi, Christopher J Herrem, Walter C Olson, et al.Melanoma Research|March 29, 2006
Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentationAnna Wankowicz-Kalinska, Robbie B Mailliard, Kathleen Olson, et al.The Journal of Experimental Medicine|February 21, 2002
Complementary dendritic cell-activating function of CD8+ and CD4+ T cells: helper role of CD8+ T cells in the development of T helper type 1 responsesRobbie B Mailliard, Shinichi Egawa, Quan Cai, et al.Pageof 15